Nintedanib for better pregnancy outcomes in adenomyosis
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests if the drug nintedanib can improve pregnancy rates in women with adenomyosis who are undergoing IVF. It is for women who have at least one high-quality frozen embryo and want to see if this medication helps the embryo implant successfully.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 38 years old
- You have been diagnosed with infertility and have at least one good-quality frozen embryo
- You have adenomyosis, confirmed by MRI or ultrasound in the last 3 months
- Your BMI is between 18 and 27
- You have regular periods and normal ovarian reserve
- You are willing to follow the trial rules and not join other trials
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adjusting the length of pre-treatment with a hormone blocker (GnRH agonist) and adding letrozole before a frozen embryo transfer can improve pregnancy outcomes for people with adenomyosis.
This trial tests whether adding letrozole (a medication that lowers estrogen) to standard hormone therapy helps women with adenomyosis have a better chance of pregnancy during in vitro fertilization (IVF). If you have adenomyosis and are planning an IVF cycle with one embryo transfer, this study may be a good fit.
This study follows people with adenomyosis to see which treatments work best for pain and heavy bleeding. It may help doctors find better ways to manage symptoms.
This trial tests if linzagolix can help women with adenomyosis who have had two or more failed embryo transfers. It aims to improve the chance of a successful pregnancy in a future transfer.
This trial looks at whether frozen embryo transfer can help women with adenomyosis (a condition where the inner lining of the uterus grows into its muscle wall) who have trouble getting pregnant. It aims to understand if this method improves pregnancy chances.
This study tests whether using a hormone medication (GnRH agonist) before a frozen embryo transfer helps women with adenomyosis. If you have adenomyosis and are planning a frozen embryo transfer, this trial will help compare results with or without the pre-treatment.
Hear when a new Adenomyosis of Uterus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.